In order to obtain this action we must pay 12,12$ right now, In this post we are going to talk about the listed company Enanta Pharmaceuticals Inc, its leaders are Jay R. Luly (President, Chief Executive Officer & Director), Nathalie Adda (Chief Medical Officer & Senior Vice President), Paul J. Mellett (CFO & Senior VP-Finance & Administration), Yat Sun Or (CSO, Senior Vice President-Research & Development), they lead it to work in Biotechnology: In Vitro & In Vivo Diagnostic Substances especially in the North America region.
The closing price of the stock yesterday was desconocido$.
With an intraday difference of 12,54$ moving between 12,06$ and 13,02$, it is a notable difference that allows quick purchases and sales.
He earns an annual income of desconocido.
The last value we have registered for the opening is desconocido.
One of the most interesting values to assess whether the price of a share is low or high is the minimum and maximum price of the last 52 weeks, in this case it has varied between 0,00$ and 0,00$.
EPS is the net profit that the company has obtained, after paying taxes, divided by the number of total shares it has in circulation. This value is higher the better the company has done, although with some nuances since it can increase if the number of shares for sale decreases, or it can decrease if things that have happened in just a few months are charged annually. For this action the BPA is [BPA].
Buscar
